Literature DB >> 659637

The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.

G H Goldsmith, H Saito, O S Ratnoff.   

Abstract

Activation of plasminogen through surface-mediated reactions is well recognized. In the presence of kaolin, purified Hageman factor (Factor XII) changed plasminogen to plasmin, as assayed upon a synthetic amide substrate and by fibrinolysis. Kinetic studies suggested an enzymatic action of Hageman factor upon its substrate, plasminogen. Hageman factor fragments, at a protein concentration equivalent to whole Hageman factor, activated plasminogen to a lesser extent. These protein preparations were not contaminated with other agents implicated in surface-mediated fibrinolysis. Diisopropyl fluorophosphate treatment of plasminogen did not inhibit its activation by Hageman factor. These studies indicate that Hageman factor has a hitherto unsuspected function, the direct activation of plasminogen.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659637      PMCID: PMC371736          DOI: 10.1172/JCI109113

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

Review 1.  The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.

Authors:  A P Kaplan; H L Meier; R Mandle
Journal:  Semin Thromb Hemost       Date:  1976-07       Impact factor: 4.180

2.  An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

3.  Activation of plasminogen by human plasma kallikrein.

Authors:  R W Colman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

4.  Structural changes accompanying enzymatic activation of human Hageman factor.

Authors:  S D Revak; C G Cochrane; A R Johnston; T E Hugli
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

5.  Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

Authors:  D Ogston; C M Ogston; O D Ratnoff; C D Forbes
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

6.  Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma.

Authors:  K Laake; A M Venneröd
Journal:  Thromb Res       Date:  1974-02       Impact factor: 3.944

7.  Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas.

Authors:  H Saito; G Goldsmith; R Waldmann
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

8.  Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.

Authors:  C D Forbes; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1972-01

9.  Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.

Authors:  H Saito; O D Ratnoff; J S Marshall; J Pensky
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  18 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Authors:  B L Zuraw; J G Curd
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 3.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

4.  Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Georgi Georgiev; Anja Klemmer; Chelsea Brain; Paul Y Kim; Nicola J Mutch
Journal:  Blood       Date:  2016-09-30       Impact factor: 22.113

5.  Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

Authors:  A de Agostini; H R Lijnen; R A Pixley; R W Colman; M Schapira
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 6.  C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Authors:  C E Hack; A C Ogilvie; B Eisele; A J Eerenberg; J Wagstaff; L G Thijs
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Induction of proteolytic activity in serum by treatment with anionic detergents and organic solvents.

Authors:  D Berger; T L Vischer; A Micheli
Journal:  Experientia       Date:  1983-10-15

8.  Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII).

Authors:  Z Toossi; J R Sedor; M A Mettler; B Everson; T Young; O D Ratnoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli.

Authors:  S P Leytus; L K Bowles; J Konisky; W F Mangel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

10.  Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.

Authors:  M Levi; C E Hack; J P de Boer; D P Brandjes; H R Büller; J W ten Cate
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.